This study investigates advanced or metastatic solid tumors. It focuses on understanding the effects of an investigational medication when given to participants with these types of tumors.
The purpose of this study is to evaluate the safety and tolerability of the investigational medication. Researchers will examine how the body processes and responds to the treatment.
- Who can participate: Adults aged 18 and older with advanced or metastatic solid tumors may be eligible. Participants must have HR-deficient alterations, measurable lesions, and an ECOG Performance Status of 2 or less, along with meeting additional health criteria.
- Study details: Participants will receive the investigational medication, either alone or with another treatment, to assess its effects.
How understandable was the trial content above?
Hard to understand
Easy to understand